Zhao, Lingdi <br/><br/>
Combination of PD-1 blockade and RetroNectin  [electronic resource] 

 -  Immunotherapy  11 2018 
 - 1315-1323 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1750-7448 
<br/><br/><label>Standard No.: </label>10.2217/imt-2018-0125  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--immunology<br/>Cells, Cultured<br/>Combined Modality Therapy<br/>Cytokine-Induced Killer Cells--immunology<br/>Female<br/>Fibronectins--immunology<br/>Humans<br/>Immunotherapy, Adoptive--methods<br/>Lung Neoplasms--immunology<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neoplasm Staging<br/>Nivolumab--therapeutic use<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Recombinant Proteins--immunology<br/>Retrospective Studies<br/>Survival Analysis<br/>Treatment Outcome